Europe’s AstraZeneca Doubt Could Spell Disaster for Africa

Europe’s AstraZeneca Doubt Could Spell Disaster for Africa

Assessment

Interactive Video

Business, Biology, Social Studies

University

Hard

Created by

Quizizz Content

FREE Resource

The video discusses the challenges in global vaccine distribution, focusing on the European handling of vaccine perception and its impact on public confidence. It highlights the issues faced by Africa, Latin America, and India in accessing vaccines, and the complications arising from the South African variant. The discussion also covers the need for both innovative and traditional vaccines, emphasizing the importance of low-cost options for low and middle-income countries. Efforts to produce vaccines and the funding challenges involved are also explored.

Read more

5 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What was a major concern regarding the European countries' handling of vaccine distribution?

Lack of vaccine supply

Public perception and confidence

High cost of vaccines

Delayed regulatory approvals

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Which region is highlighted as being significantly influenced by France's vaccine decisions?

Latin America

Southeast Asia

Francophone Africa

Eastern Europe

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is a major challenge faced by Africa and Latin America in the context of vaccine distribution?

Excessive regulatory hurdles

Insufficient vaccine availability

Lack of international support

Overproduction of vaccines

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Which countries have bypassed international regulatory authorities in their vaccine distribution efforts?

USA and UK

India and Brazil

Germany and France

Russia and China

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is a proposed solution to address the vaccine gap in low and middle-income countries?

Accelerating low-cost recombinant protein vaccines

Relying on WHO for all vaccine distribution

Developing high-cost vaccines

Focusing solely on mRNA vaccines